Claspin (CLSPN)

The CLSPN gene encodes Claspin, a protein crucial for checkpoint-mediated cell cycle arrest in response to DNA replication stress or damage. Claspin functions as a mediator, facilitating ATR-dependent phosphorylation and activation of Chk1, thereby contributing to the DNA damage response, cell cycle arrest, and maintenance of genomic integrity. The literature describes multiple transcript variants of CLSPN, encoding different isoforms, some of which may arise from alternative splicing events. However, there is no recognized "CLSPN divergent transcript" as a distinct, therapeutically relevant entity, target, or standard term in the current biomedical literature. The term "CLSPN divergent transcript" (CLSPN-DT) may be a confusion with splice variants or with nomenclature used for noncoding RNAs associated with many genes, but GenBank, HGNC, and major functional genomics resources do not recognize this symbol for CLSPN. Summary of core issues: "CLSPN divergent transcript" is not a standard or recognized molecule, gene, or target in public biomedical data. All known information refers to CLSPN/Claspin, for which alternative splicing exists, but individual divergent transcripts have not been commonly named or described as "CLSPN-DT." The CLSPN gene itself encodes a cell cycle checkpoint mediator important in cancer and genomic stability, but is not a direct drug target—nor does "CLSPN divergent transcript" represent a unique therapeutic node.

Other names

ClaspinCLSPN

Not applicable for "CLSPN divergent transcript"; for Claspin, not directly targeted by drugs.